Distinct localization and function of 1,4,5IP3 receptor subtypes and the 1,3,4,5IP4 receptor GAP1IP4BP in highly purified human platelet membranes

被引:58
作者
El-Daher, SS
Patel, Y
Siddiqua, A
Hassock, S
Edmunds, S
Maddison, B
Patel, G
Goulding, D
Lupu, F
Wojcikiewicz, RJH
Authi, KS
机构
[1] Thrombosis Res Inst, Platelet Sect, London SW3 6LR, England
[2] SUNY Hlth Sci Ctr, Dept Pharmacol, Syracuse, NY 13210 USA
关键词
D O I
10.1182/blood.V95.11.3412.011k03_3412_3422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet activation is associated with an increase of cytosolic Ca++ levels. The (IP3)-I-1,4,5 receptors [(IP3R)-I-1,4,5] are known to mediate Ca++ release from intracellular stores of many cell types. Currently there are at least 3 distinct subtypes of (IP3R)-I-1,4,5-type I, type II, and type III-with suggestions of distinct roles in Ca++ elevation. Specific receptors for (IP4)-I-1,3,4,5 belonging to the GAP1 family have also been described though their involvement with Ca++ regulation is controversial. In this study we report that platelets contain all 3 subtypes of (IP3R)-I-1,4,5 but in different amounts. Type I end type II receptors are predominant. In studies using highly purified platelet plasma (PM) and intracellular membranes (IM) we report a distinct localization of these receptors, The PM fractions were found to contain the type III (IP3R)-I-1,4,5 and GAPI1(IP4BP) in cont rast to IM, which contained type I (IP3R)-I-1,4,5. The type II receptor exhibited a dual distribution. In studies examining the labeling of surface proteins with biotin in intact platelets only the type III (IP3R)-I-1,4,5 was significantly labeled. Immunogold studies of ultracryosections of human platelets showed significantly more labeling of the PM with the type III receptor antibodies than with type I receptor antibodies. Ca++ flux studies were carried out with the PM to demonstrate in vitro function of inositol phosphate receptors, Ca++ release activities were present with both (IP3)-I-1,4,5 and (IP4)-I-1,3,4,5 (EC50 = 1.3 and 0.8 mu mol/L, respectively). Discrimination of the Ca++-releasing activities was demonstrated with cyclic adenosine monophosphate (cAMP)-dependent protein kinase (cAMP-PK) specifically inhibiting (IP3)-I-1,4,5 but not (1,3),(IP4)-I-4,5-. induced Ca++ flux. In experiments with both PM and intact platelets, the (1,4,5)IP(3)Rs but not GAP1(IP4BP) were found to be substrates of cAMP-PK and cGMP-PK, Thus the Ca++ flux property of (IP4)-I-1,3,4,5 is insensitive to cAMP-PK, These studies suggest distinct roles for the (IP3R)-I-1,4,5 subtypes in Ca++ movements, with the type III receptor and GAP1(IP4BP) associated with cation entry in human platelets and the type I receptor involved with Ca++ release from intracellular stores. (Blood. 2000;95:3412-3422) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3412 / 3422
页数:11
相关论文
共 71 条
[1]   INOSITOL 1,4,5-TRISPHOSPHATE-INDUCED RELEASE OF SEQUESTERED CA-2+ FROM HIGHLY PURIFIED HUMAN-PLATELET INTRACELLULAR MEMBRANES [J].
AUTHI, KS ;
CRAWFORD, N .
BIOCHEMICAL JOURNAL, 1985, 230 (01) :247-253
[2]   LOCALIZATION OF THE [P-32] IP3 BINDING-SITE ON HUMAN PLATELET INTRACELLULAR MEMBRANES ISOLATED BY HIGH-VOLTAGE FREE-FLOW ELECTROPHORESIS [J].
AUTHI, KS .
FEBS LETTERS, 1992, 298 (2-3) :173-176
[3]  
Authi KS, 1997, HANDB EXP PHARM, V126, P325
[4]   Expression of human TRPC genes in the megakaryocytic cell lines MEG01, DAMI and HEL [J].
Berg, LP ;
Shamsher, MK ;
ElDaher, SS ;
Kakkar, VV ;
Authi, KS .
FEBS LETTERS, 1997, 403 (01) :83-86
[5]   CAPACITATIVE CALCIUM-ENTRY [J].
BERRIDGE, MJ .
BIOCHEMICAL JOURNAL, 1995, 312 :1-11
[6]   ACTIVATION OF CA2+ ENTRY INTO ACINAR-CELLS BY A NON-PHOSPHORYLATABLE INOSITOL TRISPHOSPHATE [J].
BIRD, GS ;
ROSSIER, MF ;
HUGHES, AR ;
SHEARS, SB ;
ARMSTRONG, DL ;
PUTNEY, JW .
NATURE, 1991, 352 (6331) :162-165
[7]  
BIRD GS, 1993, J BIOL CHEM, V268, P21486
[8]   LOCALIZATION AND IDENTIFICATION OF CA(2+)ATPASES IN HIGHLY PURIFIED HUMAN PLATELET PLASMA AND INTRACELLULAR MEMBRANES - EVIDENCE THAT THE MONOCLONAL-ANTIBODY PL/IM-430 RECOGNIZES THE SERCA-3 CA(2+)ATPASE IN HUMAN PLATELETS [J].
BOKKALA, S ;
ELDAHER, SS ;
KAKKAR, VV ;
WUYTACK, F ;
AUTHI, KS .
BIOCHEMICAL JOURNAL, 1995, 306 :837-842
[9]  
BUSH KT, 1994, J BIOL CHEM, V269, P23694
[10]   Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation [J].
Cavallini, L ;
Coassin, M ;
Borean, A ;
Alexandre, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5545-5551